Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications

Collapse authors list.
Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Steven, Kurdi, Amanj, Gulbinovič, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz et al (show 38 more authors) , Rothe, Celia C, Hoxha, Iris, Malaj, Admir, Hierländer, Christian, Sauermann, Robert, Hamelinck, Wouter, Mitkova, Zornitza, Petrova, Guenka, Laius, Ott, Sermet, Catherine, Langer, Irene, Selke, Gisbert, Yfantopoulos, John, Joppi, Roberta, Jakupi, Arianit, Poplavska, Elita, Greiciute-Kuprijanov, Ieva, Bonanno, Patricia Vella, Piepenbrink, JF Hans, de Valk, Vincent, Hagen, Carolin, Ringerud, Anne Marthe, Plisko, Robert, Wladysiuk, Magdalene, Marković-Peković, Vanda, Grubiša, Nataša, Ponorac, Tatjana, Mardare, Ileana, Novakovic, Tanja, Parker, Mark, Fürst, Jurij, Tomek, Dominik, Cortadellas, Mercè Obach, Zara, Corinne, Juhasz-Haverinen, Maria, Skiold, Peter, McTaggart, Stuart and Haycox, Alan (2019) Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications. Generics and Biosimilars Initiative Journal, 8 (2). 49 - 70.

Text Accepted publication Godman et al.docx - Accepted Version Download (343kB)